Oppenheimer & Co. Inc. Trims Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Oppenheimer & Co. Inc. cut its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 7.5% during the third quarter, HoldingsChannel reports. The fund owned 246 shares of the medical instruments supplier’s stock after selling 20 shares during the period. Oppenheimer & Co. Inc.’s holdings in Mettler-Toledo International were worth $369,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Orion Portfolio Solutions LLC lifted its stake in shares of Mettler-Toledo International by 3.0% in the 1st quarter. Orion Portfolio Solutions LLC now owns 696 shares of the medical instruments supplier’s stock valued at $927,000 after purchasing an additional 20 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in Mettler-Toledo International by 17.1% in the 1st quarter. Advisors Asset Management Inc. now owns 1,366 shares of the medical instruments supplier’s stock valued at $1,819,000 after buying an additional 199 shares during the period. Toronto Dominion Bank lifted its position in Mettler-Toledo International by 47.9% in the first quarter. Toronto Dominion Bank now owns 12,772 shares of the medical instruments supplier’s stock valued at $17,003,000 after buying an additional 4,135 shares during the last quarter. Capital Research Global Investors boosted its stake in Mettler-Toledo International by 40.0% during the first quarter. Capital Research Global Investors now owns 14,199 shares of the medical instruments supplier’s stock worth $18,903,000 after buying an additional 4,058 shares during the period. Finally, Epoch Investment Partners Inc. increased its position in shares of Mettler-Toledo International by 40.9% during the first quarter. Epoch Investment Partners Inc. now owns 81,234 shares of the medical instruments supplier’s stock valued at $108,146,000 after acquiring an additional 23,593 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on MTD. JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Evercore ISI upped their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Stifel Nicolaus lowered their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Finally, Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,338.75.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Up 2.4 %

NYSE MTD opened at $1,195.00 on Friday. The business’s 50-day moving average price is $1,365.15 and its 200 day moving average price is $1,398.13. The firm has a market cap of $25.21 billion, a P/E ratio of 32.22, a P/E/G ratio of 3.83 and a beta of 1.16. Mettler-Toledo International Inc. has a 52-week low of $1,059.08 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.